The Scientific symposium „Gene Editing – from Research to Industry“ will be held in Vilnius on October 25, 2022 and will be covering the success stories of research outcomes in the field of gene editing with the focus on introduction to the industry applications. The conference agenda will cover CRISPR molecular tools applications for various products and will showcase the successful collaborations between public and private researchers.
The forthcoming conference program will attract a wide range of genetic engineering professionals from academia and industry. The event will create excellent opportunities for collaboration between different sectors and will be a great addition for the European Industrial Biotechnology and Bioeconomy Forum (EFIB22).
EFIB22, which will take place on October 26-27 in Vilnius, is Europe’s primary conference dedicated to the innovation and commercial delivery of industrial biotechnology and the bioeconomy. EFIB will include a LBTA organized Scientific symposium, followed by two days dedicated to how industrial biotechnology is contributing to transforming sectors, consumer choices and economic ecosystems, enabling a more competitive and sustainable Europe.
Scientific symposium opening
Prof. Virginijus Šikšnys, Vilnius University
CRISPR & transistors
Dr. Kiana Aran, Cardea Bio
Developing genome editing tools for applications in cell therapy
Jonathan D. Chesnut, PhD, Thermo Fisher Scientific
Harnessing the diversity of CRISPR-Cas proteins for genome editing
Dr. Giedrius Gasiūnas, CasZyme
Application of CRISPR-Cas in agriculture: tools, technology, and product development
Joshua K. Young, Corteva Agrisciences
Gene writing in mammalian genomes
Marc Güell, Integra Therapeutics
Scientific symposium closing
Participation in the Scientific symposium is free of charge, but pre-registration is required. Participation registration deadline is October 23, 2022.
Seven Tips | Conference and Event Agency
Legal name: UAB „Kalanis”
Address: Rūdninkų 18, Vilnius